Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026?
Key takeaways
- (UPB) the Best Low Priced Stocks to Get Rich in 2026?
- The company’s negative returns are understandable, considering its 572% upside potential.
- Copyright: dolgachov / 123RF Stock Photo
Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026? Rameen Kasana Tue, June 23, 2026 at 10:36 PM GMT+7 2 min read UPB JPM Upstream Bio, Inc. (NASDAQ:UPB) is among the best low priced stocks to get rich in 2026. On June 12, JPMorgan significantly trimmed the price target on Upstream Bio, Inc. (NASDAQ:UPB) to $8 from $35, while downgrading the stock from Overweight to Neutral. In a research note, the analyst said that other peers in asthma are also set to generate new data over the course of the company’s Verekitug’s late-stage development. Thus, the results from these competitors are important to understand where the company’s product stands.
According to JPMorgan, the rest of the year and beyond appear as an execution period for the company, with “relatively sparse near-term stock-moving catalysts.” The firm finds it difficult to see a path to upside in the near term, especially given the company’s additional cash needs to power phase 3 development. The company’s negative returns are understandable, considering its 572% upside potential. With strong potential for future gains, Upstream Bio, Inc. (NASDAQ:UPB) is among the best low-priced stocks to get rich in 2026.
Copyright: dolgachov / 123RF Stock Photo